Labcorp Holdings Inc. ·LH

Three operating presidents report directly to the CEO

Health Care · Fortune #328 · Hybrid structure · 65K employees · Burlington, North Carolina

View as of:
5
CEO span
↓ tighter than peers (avg 9)
5
Avg span
wide
2
Max depth
2 levels
4.8 yr
Avg tenure
stable vs FY2024
60%
Internal hires
↑ above industry avg
Consolidated financials FY2025 · period end 2025-12-31 · 10-K
Revenue
$14.0B
Operating income
$1.4B
Net income
$876M
Total assets
$18.4B
Shares out
82M

Sourced from Labcorp Holdings Inc. DEF 14A · filed 2026-04-10 ↗ View on SEC

Interactive org chart

Labcorp Holdings Inc. organizational chart

Explore the executive structure, reporting layers, and scenario-ready operating model from public filings.

Open editable chart

Three operating presidents report directly to Labcorp’s CEO, an unusual choice for a diagnostics and CRO hybrid. This page maps the executive structure, key leaders, recent changes, and compares Labcorp’s flat operating model with major healthcare services peers.

What to model

Use the chart to test org decisions, not just view reporting lines

Start with the public baseline, then use the scenario views and source-backed changes to ask what happens when leadership, span, or team ownership shifts.

Latest signal Mark S. Schroeder departed as EVP, President Diagnostics and COO

Announced retirement effective April 1, 2026.

Source · See change log

Scenario views in the chart

  • Add Chief Operating Officer Appoint a new COO to consolidate Diagnostics and Central Labs operations and reduce CEO span.
  • Consolidate Diagnostics under Central Labs Move Diagnostics leadership under the Central Laboratories president to streamline U.S. lab operations.

Atlas work this supports

  • Connect Workday or UKG Get these analytics for YOUR org — tenure, span of control, headcount, automatically from your HRIS.
  • Connect Salesforce Map your target accounts like this. Import contacts, visualize decision chains, plan multi-threading.
  • Plan a Reorg Use this as a starting point. Model scenarios, compare structures, present options to your board.

The people

Who's running this

6 executives identified as Named Executive Officers in the most recent SEC proxy. Bar length scales with tenure.

Adam H. Schechter

Chairman, President and Chief Executive Officer

Executive

6 yr

5 reports

Julia A. Wang

Executive Vice President and Chief Financial Officer

Finance

1 yr

0 reports

internal

Megan D. Bailey

Executive Vice President and President, Central Laboratories and International

Central Laboratories

3 yr

0 reports

internal

Brian J. Caveney

Executive Vice President and President, Early Development Research Laboratories and Chief Medical and Scientific Officer

Early Development Research

7 yr

0 reports

internal

Mark S. Schroeder

Former Executive Vice President and President, Diagnostics and Chief Operations Officer

Diagnostics

8 yr

0 reports

Kathryn W. Kyle

Executive Vice President, Chief Legal Officer and Corporate Secretary

Legal

1 yr

0 reports

The pay

Executive compensation

From the most recent DEF 14A Summary Compensation Table. 1 named executive officers disclosed. Bar length scales with total compensation.

Adam H. Schechter $18.3M
Base salary
$1.44M
Bonus
$2.75M
Stock awards
$11.40M
Option awards
$2.06M
Non-equity incentive
$688K
Fiscal year
FY2025
Source
SEC DEF 14A ↗

The businesses

How Labcorp Holdings Inc. divides the work

3 divisions report into the group CEO. Tile size scales with estimated headcount.

Central Laboratories and International

30K employees

President (Megan D. Bailey)

Core global clinical laboratory testing and international operations.

Early Development Research Laboratories

15K employees

President (Brian J. Caveney)

Drug development, preclinical, and early clinical research services.

Diagnostics Laboratories

18K employees

Former President (Mark S. Schroeder)

U.S. diagnostics operations pending post-COO retirement reorganization.

The thesis

Why this org is unusual

Three operating presidents — Central Laboratories, Early Development Research, and Diagnostics — report directly to the CEO, rather than being consolidated under a single COO.

This structure reflects Labcorp’s dual diagnostics and drug-development model following the Fortrea spin-off, with P&L ownership sitting high in the org. The CFO and Chief Legal Officer are the primary functional leaders at the CEO level, keeping the structure relatively flat for a ~65k-employee enterprise.
  • Multiple operating presidents report directly to CEO
  • COO role lapses after April 2026 retirement

The comparison

How Labcorp Holdings Inc. stacks up

Compared with peers like Quest Diagnostics and Thermo Fisher Scientific, Labcorp places more operating presidents directly under the CEO rather than routing them through a COO. This increases CEO span but preserves accountability for major business lines. The absence of a permanent COO after Schroeder’s retirement …

C-suite size

Labcorp Holdings Inc.
6
Quest Diagnostics
8
Thermo Fisher Scientific
10
Danaher
9
IQVIA
9

Reporting depth

Labcorp Holdings Inc.
2 levels
Quest Diagnostics
4 levels
Thermo Fisher Scientific
5 levels
Danaher
5 levels
IQVIA
5 levels

Avg C-suite tenure

Labcorp Holdings Inc.
5 yr
Quest Diagnostics
6 yr
Thermo Fisher Scientific
7 yr
Danaher
6 yr
IQVIA
5 yr

Has COO / Has CAIO

Labcorp Holdings Inc. — no COO — no CAIO
Quest Diagnostics ✓ COO — no CAIO
Thermo Fisher Scientific ✓ COO — no CAIO
Danaher — no COO — no CAIO
IQVIA ✓ COO — no CAIO

Current signals

What changed recently

The most consequential change is the April 2026 retirement of COO Mark Schroeder, leaving operations presidents reporting directly to the CEO.

  • departed
    Mark S. Schroeder EVP, President Diagnostics and COO

    Announced retirement effective April 1, 2026.

    Source
  • new
    John H. Sampson, M.D., Ph.D. Director

    Appointed to Board effective February 9, 2026.

    Source

Leadership Timeline

Year-over-year executive structure based on SEC proxy and annual filings.

FY2025
DEF 14A filed 2026-04-10
CEO
Adam H. Schechter
CEO span
5
C-suite
5
Avg tenure
4.8 yr

COO retirement announced, signaling possible structural shift.

Named executive officers (5)
  • Adam H. Schechter - Chairman, President and CEO since 2019
  • Julia A. Wang - EVP and CFO since 2024
  • Megan D. Bailey - EVP, President Central Labs since 2022
  • Brian J. Caveney - EVP, President Early Development since 2018
  • Mark S. Schroeder - EVP, President Diagnostics and COO since 2017
FY2024
DEF 14A filed 2025-04-04
CEO
Adam H. Schechter
CEO span
5
C-suite
5
Avg tenure
5.2 yr

Post–holding company reorganization year.

Named executive officers (5)
  • Adam H. Schechter - Chairman, President and CEO since 2019
  • Julia A. Wang - EVP and CFO since 2024
  • Megan D. Bailey - EVP, President Central Labs since 2022
  • Brian J. Caveney - EVP, President Early Development since 2018
  • Mark S. Schroeder - EVP, President Diagnostics and COO since 2017
FY2023
DEF 14A filed 2024-04-05
CEO
Adam H. Schechter
CEO span
5
C-suite
5
Avg tenure
5.8 yr

Fortrea spin-off reshaped enterprise scope.

Named executive officers (4)
  • Adam H. Schechter - Chairman, President and CEO since 2019
  • Megan D. Bailey - EVP, President Central Labs since 2022
  • Brian J. Caveney - EVP, President Early Development since 2018
  • Mark S. Schroeder - EVP, President Diagnostics and COO since 2017

Year-over-year changes

FY2024 → FY2025

2025 reflected stability in structure but announced COO retirement reduced continuity going forward.

  • CEO span: 5 → 5
  • C-suite size: 5 → 5
  • Avg tenure: 5.2 → 4.8 yr
  • departed Mark S. Schroeder - COO (was COO) (DEF 14A 2026-04-10)

Frequently Asked Questions

Who is the CEO of Labcorp Holdings Inc.?

Adam H. Schechter has served as Chairman, President, and CEO since November 2019.

What type of organizational structure does Labcorp Holdings Inc. use?

Labcorp uses a hybrid structure with major operating businesses led by presidents reporting directly to the CEO.

How many direct reports does Labcorp Holdings Inc.'s CEO have?

As of 2026, the CEO has five direct reports, including three operating presidents.

How has Labcorp Holdings Inc.'s leadership changed recently?

The key change is the announced April 2026 retirement of COO Mark Schroeder and ongoing board refreshment in early 2026.

Does Labcorp Holdings Inc. have a COO?

Following Mark Schroeder’s retirement effective April 1, 2026, Labcorp does not have a named permanent COO.

Sources

  • Form 8-K, Dec 15 2025
  • Form 8-K, Feb 9 2026
  • SEC EDGAR: Labcorp Holdings Inc. DEF 14A Proxy Statement
  • SEC EDGAR: Labcorp Holdings Inc. 10-K Annual Report

Reference

Cite this page

If you reference this page in research, analysis, or news writing, use one of the formats below. Citation includes the SEC filing source where applicable.

APA 7th
Creately. (2026). Labcorp Holdings Inc. organizational structure. Creately. Retrieved , from https://creately.com/org-chart/fortune-500/labcorp-holdings/
MLA 9th
"Labcorp Holdings Inc. Organizational Structure." Creately, April 1, 2026, https://creately.com/org-chart/fortune-500/labcorp-holdings/. Accessed .
Chicago 17
Creately. "Labcorp Holdings Inc. Organizational Structure." Last modified April 1, 2026. https://creately.com/org-chart/fortune-500/labcorp-holdings/.
Original SEC source View on SEC ↗
Labcorp Holdings Inc.. DEF 14A. Filed 2026-04-10. U.S. Securities and Exchange Commission. https://www.sec.gov/Archives/edgar/data/920148/000119312526150752/lh-20260410.htm

Permanent URL: https://creately.com/org-chart/fortune-500/labcorp-holdings/ · last updated 2026-04-01

Turn this benchmark into your Atlas workspace. Import your own people data, compare spans and layers, and test scenario plans before changing the live org.
Start in Atlas Back to Fortune 500